NLRadiotherapy object

Use of radiation or radioactive compounds - Specific requirements

Yes

Applicable legal framework

Section 18 + 55 Act on Pharmaceuticals

Additional Information

The State Office for Nuclear Safety shall provide opinions on the marketing authorisations and clinical trials of radiopharmaceuticals. SUKL shall request the opinion of the State Office for Nuclear Safety, which shall issue such opinion within 30 days of delivery of the request.

This project (ECRIN Integrating Activity/ECRIN-IA) has received funding from the European Union’s Seventh Framework Programme for research, technological development and demonstration under grant agreement no 284395
Feedback